# A Study Of PF-03732010 In Patients With Advanced Solid Tumors

> **NCT00557505** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 43 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** PF-03732010

## Key facts

- **NCT ID:** NCT00557505
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12
- **Primary completion:** 2011-02
- **Final completion:** 2011-02
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2012-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00557505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00557505, "A Study Of PF-03732010 In Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00557505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*